KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Return on Equity (2016 - 2025)

Astrana Health's Return on Equity history spans 15 years, with the latest figure at 0.01% for Q3 2025.

  • For Q3 2025, Return on Equity fell 7.0% year-over-year to 0.01%; the TTM value through Sep 2025 reached 0.01%, down 7.0%, while the annual FY2024 figure was 0.07%, 2.0% down from the prior year.
  • Return on Equity for Q3 2025 was 0.01% at Astrana Health, down from 0.04% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.38% in Q1 2021 and bottomed at 0.0% in Q2 2022.
  • The 5-year median for Return on Equity is 0.09% (2023), against an average of 0.11%.
  • The largest YoY upside for Return on Equity was 27bps in 2021 against a maximum downside of -32bps in 2021.
  • A 5-year view of Return on Equity shows it stood at 0.11% in 2021, then dropped by -23bps to 0.09% in 2022, then grew by 9bps to 0.1% in 2023, then decreased by -27bps to 0.07% in 2024, then plummeted by -82bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Return on Equity are 0.01% (Q3 2025), 0.04% (Q2 2025), and 0.05% (Q1 2025).